PHI
Showing 1 - 25 of 626
Myeloproliferative Tumor, Optical Genome Mapping, Cytogenetics Trial in Amiens (Blood sample)
Recruiting
- Myeloproliferative Neoplasm
- +4 more
- Blood sample
-
Amiens, Picardie, FranceCentre Hospitalier Universitaire d'Amiens
Jan 27, 2023
Pneumonitis, SARS-CoV Infection Trial in Worldwide (GLS-1027, Placebo)
Active, not recruiting
- Pneumonitis
- SARS-CoV Infection
- GLS-1027
- Placebo
-
Baton Rouge, Louisiana
- +16 more
Jan 10, 2023
MRI Prostate in Different Prostate Health Index (Phi) Values
Recruiting
- Prostate Cancer
-
Hong Kong, Hong KongPrince of Wales Hospital, Chinese University of Hong Kong
Jun 29, 2022
Prostate Cancer in PSA Gray Zone Based on Serum PHI Combined
Recruiting
- Prostate Cancer
- PSA
- p2PSA
- +2 more
-
Shanghai, Shanghai, ChinaXinhua Hospital Affiliated to Shanghai Jiao Tong University Scho
May 5, 2022
A Research for Combination of Prostate Health Index and mpMRI
Not yet recruiting
- Prostate Cancer
- (no location specified)
Dec 16, 2021
Esophagus; Fistula, Fistula;Rectal, Complication of Surgical Procedure Trial in Milan (SPY Portable Handheld Imaging (SPY-PHI)
Recruiting
- Esophagus; Fistula
- +3 more
- SPY Portable Handheld Imaging (SPY-PHI) System with SPY-QP Software
-
Milan, ItalyLorenzo Cinelli
Aug 3, 2022
NSCLC Trial in Houston (Amivantamab, Tepotinib)
Not yet recruiting
- Non-small Cell Lung Cancer
-
Houston, TexasMD Anderson Cancer Center
Oct 9, 2023
SLN Mapping and ICG Dye for Vulvar Cancer
Not yet recruiting
- Vulva Cancer
- Indocyanine green
-
Boston, MassachusettsTufts Medical Center
Sep 6, 2023
Breast Tumor Female Trial in Lyon (Phi-Bra prototype measurements)
Not yet recruiting
- Breast Neoplasm Female
- Phi-Bra prototype measurements
-
Lyon, France
- +1 more
Oct 10, 2022
NEC, Atresia, Malrotation Trial (Perfusion assessment by means of the SPY-PHI camera)
Not yet recruiting
- NEC
- +3 more
- Perfusion assessment by means of the SPY-PHI camera
- (no location specified)
Feb 3, 2023
Solid Tumor, TNBC - Triple-Negative Breast Cancer Trial in Bengbu, Beijing (LAE005 + Afuresertib + Nab-Paclitaxel, LAE005 +
Recruiting
- Solid Tumor
- TNBC - Triple-Negative Breast Cancer
- LAE005 + Afuresertib + Nab-Paclitaxel
- +3 more
-
Bengbu, Anhui, China
- +1 more
May 19, 2022
Benign Tumor, Malignant Tumor Trial in Boston (Indocyanine green, SPY-PHI)
Recruiting
- Benign Neoplasm
- Malignant Neoplasm
- Indocyanine green
- SPY-PHI
-
Boston, MassachusettsMassachusetts General Hospital
Jan 20, 2023
Huntington Disease Trial in Paris (BV-101 Gene Therapy)
Not yet recruiting
- Huntington Disease
- BV-101 Gene Therapy
-
Paris, Ile-de-France, FranceInstitut du Cerveau (ICM), Hôpital La Pitié Salpêtrière APHP
Sep 13, 2022
Anemia in Incident Dialysis Patients Trial in Changsha (HIF-PHI, Epoetin Alfa)
Not yet recruiting
- Anemia in Incident Dialysis Patients
- HIF-PHI
- Epoetin Alfa
-
Changsha, Hunan, ChinaDepartment of Nephrology, Second Xiangya Hospital, Central South
May 20, 2021
Relapsed or Refractory Acute Myeloid Leukemia Trial in Seoul (PHI-101)
Recruiting
- Relapsed or Refractory Acute Myeloid Leukemia
-
Seoul, Korea, Republic ofSeoul National University Cancer Hospital
Apr 18, 2021
Parathyroid Vascularization During Total Thyroidectomy Using
Recruiting
- Thyroid
- +3 more
- Indocyanine green
- SPY Portable Handheld Imaging (SPY-PHI)
-
Milan, ItalySan Raffaele Hospital
May 3, 2022
Sarcoma Trial in Pittsburgh (Indocyanine green solution administered at 2.0mg/kg., Stryker SPY-PHI Imaging Device)
Recruiting
- Sarcoma
- Indocyanine green solution administered at 2.0mg/kg.
- Stryker SPY-PHI Imaging Device
-
Pittsburgh, PennsylvaniaAlma E Heyl
Mar 11, 2022
Innate CD8+ T Cells and Evolution of Tyrosine Kinase Inhibitor
Recruiting
- Leukemia
- +3 more
- Phenotyping of total and innate CD8+T cells by flow cytometry
-
Nîmes, Gard, FranceCHU de Nîmes
Jul 19, 2021
Dementia, Alzheimer, Caregiver Burden Trial in Washington, Atlanta (Prototype Intervention)
Recruiting
- Dementia
- +2 more
- Prototype Intervention
-
Washington, District of Columbia
- +3 more
Jul 18, 2022
Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Carcinoma, Platinum-Resistant Fallopian Tube Carcinoma Trial in
Unknown status
- Platinum-resistant Ovarian Cancer
- +3 more
- PHI-101 administration
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jan 16, 2021
Expression of IFN-epsilon in the Female Reproductive Tract
Completed
- Interferon Expression in the Female Reproductive Tract
- Reproductive tract and blood sampling
-
Pittsburgh, Pennsylvania
- +1 more
Dec 22, 2021
Breast Cancer, Lymph Node Mapping, Sentinel Lymph Node Biopsy Trial in Canada, United States (IC2000 and SPY-PHI, Tc-99m
Completed
- Breast Cancer
- +2 more
- IC2000 and SPY-PHI
- Tc-99m radioactive colloid and Gamma Probe
-
Scottsdale, Arizona
- +6 more
Aug 17, 2021
Anaemia Trial in Cambridge, Edinburgh, London (Daprodustat, Darbepoetin alfa, Acetylcholine)
Terminated
- Anaemia
- Daprodustat
- +4 more
-
Cambridge, Cambridgeshire, United Kingdom
- +2 more
Dec 29, 2021